These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 14579153)

  • 1. Coxsackieviral replication and pathogenicity: lessons from gene modified animal models.
    Wessely R
    Med Microbiol Immunol; 2004 May; 193(2-3):71-4. PubMed ID: 14579153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy.
    Wessely R; Klingel K; Santana LF; Dalton N; Hongo M; Jonathan Lederer W; Kandolf R; Knowlton KU
    J Clin Invest; 1998 Oct; 102(7):1444-53. PubMed ID: 9769337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CVB infection and mechanisms of viral cardiomyopathy.
    Knowlton KU
    Curr Top Microbiol Immunol; 2008; 323():315-35. PubMed ID: 18357777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of transgenic knockout models in defining the pathogenesis of viral heart disease.
    Liu P; Penninger J; Aitken K; Sole M; Mak T
    Eur Heart J; 1995 Dec; 16 Suppl O():25-7. PubMed ID: 8682095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ubiquitin-like protein ISG15 (interferon-stimulated gene of 15 kDa) in host defense against heart failure in a mouse model of virus-induced cardiomyopathy.
    Rahnefeld A; Klingel K; Schuermann A; Diny NL; Althof N; Lindner A; Bleienheuft P; Savvatis K; Respondek D; Opitz E; Ketscher L; Sauter M; Seifert U; Tschöpe C; Poller W; Knobeloch KP; Voigt A
    Circulation; 2014 Oct; 130(18):1589-600. PubMed ID: 25165091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent coxsackievirus infection: enterovirus persistence in chronic myocarditis and dilated cardiomyopathy.
    Chapman NM; Kim KS
    Curr Top Microbiol Immunol; 2008; 323():275-92. PubMed ID: 18357775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-level expression of a mutant coxsackieviral cDNA induces a myocytopathic effect in culture: an approach to the study of enteroviral persistence in cardiac myocytes.
    Wessely R; Henke A; Zell R; Kandolf R; Knowlton KU
    Circulation; 1998 Aug; 98(5):450-7. PubMed ID: 9714096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetics of coxsackievirus B cardiovirulence and inflammatory heart muscle disease.
    Tracy S; Chapman NM; Romero J; Ramsingh AI
    Trends Microbiol; 1996 May; 4(5):175-9. PubMed ID: 8727596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The molecular pathogenesis of enterovirus myocarditis. Virus persistence and chronic inflammation].
    Kandolf R
    Internist (Berl); 1995 May; 36(5):430-8. PubMed ID: 7601616
    [No Abstract]   [Full Text] [Related]  

  • 10. The tyrosine kinase p56lck is essential in coxsackievirus B3-mediated heart disease.
    Liu P; Aitken K; Kong YY; Opavsky MA; Martino T; Dawood F; Wen WH; Kozieradzki I; Bachmaier K; Straus D; Mak TW; Penninger JM
    Nat Med; 2000 Apr; 6(4):429-34. PubMed ID: 10742150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis.
    Yuan J; Liu Z; Lim T; Zhang H; He J; Walker E; Shier C; Wang Y; Su Y; Sall A; McManus B; Yang D
    Circ Res; 2009 Mar; 104(5):628-38. PubMed ID: 19168435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coxsackie B virus infection in idiopathic dilated cardiomyopathy: clinical and pharmacological implications.
    Fujioka S; Kitaura Y
    BioDrugs; 2001; 15(12):791-9. PubMed ID: 11784211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host.
    Szalay G; Sauter M; Haberland M; Zuegel U; Steinmeyer A; Kandolf R; Klingel K
    Circ Res; 2009 Apr; 104(7):851-9. PubMed ID: 19246678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly variable expression of virus receptors in the human cardiovascular system. Implications for cardiotropic viral infections and gene therapy.
    Poller W; Fechner H; Noutsias M; Tschoepe C; Schultheiss HP
    Z Kardiol; 2002 Dec; 91(12):978-91. PubMed ID: 12490988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral myocarditis: from experimental models to molecular diagnosis in patients.
    Pankuweit S; Klingel K
    Heart Fail Rev; 2013 Nov; 18(6):683-702. PubMed ID: 23070541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coxsackievirus replication and the cell cycle: a potential regulatory mechanism for viral persistence/latency.
    Feuer R; Mena I; Pagarigan RR; Hassett DE; Whitton JL
    Med Microbiol Immunol; 2004 May; 193(2-3):83-90. PubMed ID: 12925877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innate immune interleukin-1 receptor-associated kinase 4 exacerbates viral myocarditis by reducing CCR5(+) CD11b(+) monocyte migration and impairing interferon production.
    Valaperti A; Nishii M; Liu Y; Naito K; Chan M; Zhang L; Skurk C; Schultheiss HP; Wells GA; Eriksson U; Liu PP
    Circulation; 2013 Oct; 128(14):1542-54. PubMed ID: 24030499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Manipulating intestinal immunity and microflora: an alternative solution to viral myocarditis?
    Qian Q; Xiong S; Xu W
    Future Microbiol; 2012 Oct; 7(10):1207-16. PubMed ID: 23030425
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Lee YG; Park JH; Jeon ES; Kim JH; Lim BK
    J Microbiol Biotechnol; 2016 Nov; 26(11):2012-2018. PubMed ID: 27558433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-22-producing Th22 cells play a protective role in CVB3-induced chronic myocarditis and dilated cardiomyopathy by inhibiting myocardial fibrosis.
    Guo Y; Wu W; Cen Z; Li X; Kong Q; Zhou Q
    Virol J; 2014 Dec; 11():230. PubMed ID: 25547181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.